InsiderSignal.AI

InsiderSignal.ai

AORT - Artivion, Inc.

Insider Sale by Berry Lance A (EVP, COO, CFO, Treasurer)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Berry Lance A, serving as EVP, COO, CFO, Treasurer at Artivion, Inc. (AORT), sold 6,316 shares at $37.78 per share, for a total transaction value of $238,591.00. Following this transaction, Berry Lance A now holds 210,827 shares of AORT.

This sale represents a 3.00% decrease in Berry Lance A's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, March 3, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 1 day after the trade was made.

Artivion, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Berry Lance A

EVP, COO, CFO, Treasurer

Lance A. Berry is Executive Vice President, Chief Operating Officer, and Chief Financial Officer at Artivion, Inc. (NYSE: AORT), a cardiac and vascular surgery company, having been appointed CFO in December 2023 and assuming the COO role in August 2025[[1]](https://fintool.com/app/research/companies/AORT/people/lance-a-berry)[[5]](https://artivion.com/about/). He holds bachelor's and master's degrees in accounting from the University of Mississippi and is a CPA (inactive)[[1]](https://fintool.com/app/research/companies/AORT/people/lance-a-berry). Berry brings extensive medtech finance and operations expertise, having spent 18 years at Wright Medical Group in progressively senior roles, including Vice President, Corporate Controller (2002–2009), Senior Vice President and Chief Financial Officer (2009–2018), and Executive Vice President of Chief Financial and Operations Officer (2019–2020), where he led the company through its acquisition by Stryker in November 2020[[1]](https://fintool.com/app/research/companies/AORT/people/lance-a-berry)[[3]](https://www.treace.com/about-us/board-of-directors/lance-a-berry/). He began his finance career as an auditor at Arthur Andersen (1995–2002)[[1]](https://fintool.com/app/research/companies/AORT/people/lance-a-berry). In addition to his executive responsibilities at Artivion, Berry serves as an independent director and audit committee financial expert at Treace Medical Concepts, Inc. (TMCI), a position he has held since October 2022[[2]](https://fintool.com/app/research/companies/TMCI/people/lance-a-berry)[[3]](https://www.treace.com/about-us/board-of-directors/lance-a-berry/).

View full insider profile →

Trade Price

$37.78

Quantity

6,316

Total Value

$238,591.00

Shares Owned

210,827

Trade Date

Tuesday, March 3, 2026

2 days ago

SEC Filing Date

Wednesday, March 4, 2026

Filed 1 day after trade

HEALTHCAREMEDICAL DEVICES

About Artivion, Inc.

Company Overview

No company information available
View news mentioning AORT

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4499552

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime